Evan Lebois work email
- Valid
- Valid
Evan Lebois personal email
Professional Summary• 10+ years leading neuroscience drug development teams in industry R&D and academia with end-to-end research experience spanning target validation and drug discovery through clinical research• 10+ years neurologic and psychiatric disease expertise targeting AD, FTD, PD, schizophrenia, PTSD, epilepsy, neurodegenerative, and neuroinflammatory mechanisms• 10+ years developing allosteric modulators for many GPCRs and pharmacological modes• 10+ years large cross-functional drug discovery team leadership• 10+ years management and mentorship experience of colleagues, students, and interns• 7+ years identifying, negotiating, and leading external neuroscience collaborations• 3+ years validating and drugging novel microglial targets for neurodegenerative disease• 3+ years experience applying systems biology approaches to drive neuroimmunology target validation, including single cell and bulk RNA sequencing, lipidomics, and proteomics• 3+ years experience with microglia culture systems, functional, and morphological assays• Leader of complex external collaborations and academic-industry consortia• Experience designing and executing high-throughput screening assays• Experience in back-translation of human biology to animal systems• Strong experimental design skills and focus on generation of multi-modal datasets• Cross-species expertise spanning flies, rodents, primates, and humans• Excellent communication skills as demonstrated by presentations, publications, and patents• Experience bridging external opportunities and needs of internal drug discovery teams• Strategic and analytical thinker who loves problem solving and data driven decision making• Hands-on and driven manager who excels at flexible decision making to meet business needs• Very entrepreneurial colleague who delivers consistent, high quality, and timely results• Highly interdisciplinary expertise spanning neuroscience drug discovery, pharmacology, systems neuroscience, medicinal chemistry, molecular biology, and genetics• Passion for developing drugs to address unmet medical needs in brain disease• Love of critically reviewing and interpreting published literature to guide strategy• Deep network of decision makers across industry, academia, and investing communities
-
Senior Director And Head Of BiologyViolet Therapeutics Sep 2024 - PresentCambridge, Ma, Us -
Director And Head Of BiologyViolet Therapeutics Sep 2023 - PresentCambridge, Ma, Us
-
Associate Director Of NeurobiologyNido Biosciences May 2022 - Sep 2023 -
Group Leader/Senior Research ScientistBroad Institute Of Mit And Harvard 2018 - May 2022Cambridge, Ma, UsPsychiatric Disease TherapeuticsTranslational Research GroupStanley Center Therapeutics TeamStanley Center for Psychiatric Research• Lead small molecule drug discovery teams in psychiatric, neurodegenerative, and neurodevelopmental disease from target validation through lead optimization and in vivo PoC• Neuroimmunology drug discovery team leader focused on drugging novel microglial targets• Lead large cross-functional drug discovery teams from target identification and initial screening through lead-optimization• Routinely use systems biology approaches to drive neuroimmunology drug discovery programs, including single cell and bulk RNA-seq, lipidomics, and proteomics• Employ microglia culture systems to test pharmacological effects and interrogate disease mechanisms, including primary rodent microglia, microglia-neuron co-culture, iPSC-derived human microglia• Employ microglia functional assays including phagocytosis, synaptic engulfment, liposome uptake, cytokine/chemokine production, chemotaxis• Experience FACS sorting microglia, astrocytes, and neurons to enable functional studies• Design and execute fluorescence-based HTS assays (Ca2+ fluorescence, cAMP FRET, beta-arrestin luminescence)• Experience with microglia morphological analysis (e.g. sholl analysis)• Investigate psychiatric disease mechanism at human, animal, and cellular levels of analysis• Use Broad genomics resources to ground drug discovery efforts in human biology• Set and oversee project budgets• Establish and maintain collaborations with external CROs, academic collaborators, and key opinion leaders in the field• Regularly troubleshoot experiments to drive decision making• Establish and direct group strategy and operations to set priorities -
Business Development And Neuroscience Alliance ManagementPfizer 2017 - 2018• Bridged external stakeholders and internal teams at all levels in a large, highly-matrixed large pharmaceutical setting• Identified and prioritized external collaborations and assets to strategically meet internal stakeholder needs• Identified gaps in neuroscience portfolio strategy from early drug discovery programs to early clinical development stages• Identification and engagement of key external collaborators and negotiation of collaboration scope and terms• Developed, led due diligence, and delivered innovative proposals for investment in high impact neuroscience opportunities• Led cross-functional due diligence teams to drive evaluation process of potential portfolio companies and neuroscience assets• Built consensus around scientific and business needs of potential opportunities• Rigorously analyzed data of potential portfolio companies• Created presentations and pitched potential high impact investments to senior leadership for funding• Served as project lead to manage and support ongoing investments• Helped to provide competitive analysis and market analysis to project teams• Experience with financial models and financial analyses• Deeply in command of central nervous system drug discovery literature, cutting edge science, and competitive landscape• Leader of complex academic-industry research programs and partnerships• Prepared and maintained internal documentation on potential assets to acquire, companies to partner with, and KOLs to reach out to
-
Senior Scientist, Neuroscience Research UnitPfizer 2014 - 2018• Significant management experience as demonstrated by 4 years as research project lead for neurologic and psychiatric disease teams of up to 15 FTE• Project leadership experience from early discovery to early clinical studies• Designed and executed behavioral pharmacology, neuropathology, in vitro and in vivo electrophysiology studies• Significant surgical experience implanting silicon probe recording arrays, recording, and analyzing high-density neurophysiology data• Successfully secured funding for, implemented, and led external neuroscience collaborations to complement portfolio efforts• Established animal (NHP)-to-human translational platforms to drive novel endpoint development by leveraging eye-tracking, EEG, behavioral, intracranial recording, neuroimaging, and molecular approaches• Drove translational biomarker strategy at preclinical/clinical interface using multiple modalities (e.g. functional, fluid) by building internal teams and external collaborations with academic faculty• Experience back-translating human findings to animal systems• Pfizer preclinical lead for large academic-industry consortia• Entrepreneurial experience successfully pitching to corporate venture funds, drawing up research agreements, managing partnerships, and building teams• Strong oral and written communication as demonstrated by presentations to senior leadership, internal governance committees, and scientific publications• Ability to adapt to a highly matrixed and dynamic environment• Effective builder of internal and external cross-functional teams• Conducted due diligence to evaluate potential investment opportunities• Effective at influencing key stakeholders and driving decisions• Numerous cross-functional collaborations in chemistry, chemical biology, immunology and inflammation, translational medicine, clinical development, business development• Troubleshoot experiments to drive decision making• Compose and review FDA regulatory documents
-
Graduate StudentEmory University 2010 - 2014Atlanta, Ga, UsPhD, NeuroscienceMentors: Allan Levey, MD, PhD and Joseph Manns, PhDDepartments of Neurology and PsychologyCenter for Neurodegenerative DiseaseAlzheimer's Disease Research Center• Studied M1 muscarinic acetylcholine receptor (mAChR) activator effects on memory and neuropathology in transgenic Alzheimer's mice as well as hippocampal network dynamics in behaving rats• Experience in a number of research methods including behavioral pharmacology assays, immunohistochemistry, immunoperoxidase staining, ELISA assays, histology, pharmacokinetic assays, primary neuron culture assays, viral transduction• Used high-density in vivo tetrode recordings in awake, behaving rats to gain mechanistic insights into drug effects on memory circuitry• Extensive major survival surgery experience implanting tetrode recording arrays, recording, and analyzing high-density neurophysiology data• Extensive MATLAB and signal processing expertise• Strong written communication skills as demonstrated by conference presentations and scientific research publications• Taught undergraduate neurobiology courses• Strong management skills as demonstrated by mentoring of junior colleagues• Regularly troubleshoot experiments to drive decision making• Served as a peer reviewer for several scientific journals -
Graduate StudentVanderbilt University Medical Center 2007 - 2010Nashville, Tennessee, UsMS, PharmacologyMentors: P. Jeffrey Conn, PhD and Craig Lindsley, PhDVanderbilt Center for Neuroscience Drug DiscoveryDepartments of Pharmacology and Chemistry• Worked as a medicinal chemist, molecular pharmacologist, behavioral pharmacologist, and slice electrophysiologist on neurologic and psychiatric drug discovery programs• Extensive hit-to-lead small molecule therapeutic synthesis and characterization experience in in vitro and in vivo assays• Developed several novel chemotypes of M1 selective activators licensed to Acadia Pharmaceuticals (2020)• Routinely developed and ran plate-based high-throughput screening assays (e.g. calcium fluorescence and cAMP assays)• Synthesized and characterized novel small molecule therapeutics across multiple CNS targets, modes of pharmacology, neurologic and psychiatric indications to gain mechanistic insights: - Targets: M1, M4, M5, mGlu4, mGlu5, GlyT1 - Modes of pharmacology: PAM, NAM, agonist, antagonist - Indications: schizophrenia, Alzheimer's disease, Parkinson's disease, PTSD, fragile X, dystonia, and drug addiction• Specialized in allosteric modulator synthesis and characterization• Significant experience as project team member acting with PK/PD, molecular and behavioral pharmacology, chemistry, and neuroimaging colleagues to drive drug discovery programs• Contributed as a named inventor to several patents• Strong written communication skills as demonstrated by 12 high impact scientific publications covering multiple CNS drug targets and indications• Presented research at numerous national and international conferences• Strong management skills as demonstrated by serving as a primary mentor to junior colleagues• Served as a peer reviewer for several primary research journals -
Undergraduate Research FellowImperial College London 2007 - 2007London, GbSummer undergraduate research fellowship at the Glycobiology Training, Research and Infrastructure Centre (GlycoTRIC)Mentor: Kurt Drickamer, PhD• Summer undergraduate research fellowship at the Glycobiology Training, Research and Infrastructure Centre (GlycoTRIC)• Cloned and characterized human lectins • Acquired glycobiology expertise• Performed SDS-PAGE, affinity chromatography, DNA sequencing, DNA maxipreps, cloning cDNAs into plasmid expression vectors for expression in e. Coli, lyophilization -
Undergraduate StudentUniversity Of Delaware 2003 - 2007Newark, De, UsBS, Biology (with cell/molecular biology/genetics concentration)BS, ChemistryBS, BiochemistryUndergraduate Thesis Advisor: Erica Selva, PhD• Acquired 4 years of molecular genetics experience using Drosophila• Studied the effects of protein glycosylation on CNS development• Awarded 3 competitive summer research fellowships, including HHMI • Acquired skills in molecular genetics, PCR, immunostaining, genomic DNA preparation, agarose gel electrophoresis, light and confocal microscopy, histological staining and paraffin sectioning• Presented research findings at internal and external scientific meetings• Invited to give a platform talk as part of the “Extracellular Matrix at the Organism Scale” symposium session during the 2007 Experimental Biology meeting in Washington DC
Evan Lebois Skills
Evan Lebois Education Details
-
Emory UniversityNeuroscience -
Vanderbilt UniversityNeuropharmacology And Medicinal Chemistry
-
University Of DelawareChemistry
-
University Of DelawareBiology (Cell/Molecular Biology/Genetics Concentration)
-
University Of DelawareBiochemistry
Frequently Asked Questions about Evan Lebois
What company does Evan Lebois work for?
Evan Lebois works for Violet Therapeutics
What is Evan Lebois's role at the current company?
Evan Lebois's current role is CNS drug discovery expert.
What is Evan Lebois's email address?
Evan Lebois's email address is el****@****ute.org
What schools did Evan Lebois attend?
Evan Lebois attended Emory University, Vanderbilt University, University Of Delaware, University Of Delaware, University Of Delaware.
What skills is Evan Lebois known for?
Evan Lebois has skills like Immunohistochemistry, Pharmacology, Drug Discovery, Molecular Biology, Sds Page, Confocal Microscopy, In Vivo Electrophysiology, Systems Neuroscience, Pharmaceutical Industry, Matlab, Molecular Genetics, Western Blotting.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial